Brief: Aytu Bioscience Inc - Q2 Net Revenue $15.1 Million, Compared To $13.5 Million In Q1 2021
Feb 11 (Reuters) - Aytu BioScience Inc AYTU.O :
* AYTU BIOSCIENCE INC - Q2 NET REVENUE WAS $15.1 MILLION,
COMPARED
TO $13.5 MILLION IN Q1 2021
* AYTU BIOSCIENCE INC - CASH, CASH EQUIVALENTS AND
RESTRICTED CASH
OF $62.3 MILLION ON DECEMBER 31, 2020
* AYTU BIOSCIENCE INC - QTRLY LOSS PER SHARE $0.72
Source text for Eikon: [ID: https://bit.ly/3d59abS]
Further company coverage: AYTU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aytu Biopharma
See all newsAytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales
Aytu Biopharma Inc expected to post a loss of 32 cents a share - Earnings Preview
Aytu BioPharma Q3 revenue falls amid EXXUA launch
Aytu BioPharma Q2 revenue beats expectations